DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DiscGenics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11190
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. It provides products such as Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with moderately degenerated discs; and Surgical Discogenic Cell Therapy (SDCT), developed for treating patients with herniated discs. DiscGenics develops adult human disc stem cells within tissue engineering to develop new approaches. The company provides technology Discosphere which is a novel method used to efficiently isolate stem-like progenitor cells from human adult intervertebral disc tissues. DiscGenics is headquartered in Salt Lake City, Utah, the US.

DiscGenics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DiscGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DiscGenics Inc, Medical Devices Deals, 2012 to YTD 2018 9
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DiscGenics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
DiscGenics Raises USD14 Million in Series B Financing 11
Discgenics To Raise US$3 Million In Venture Financing 12
Partnerships 13
CTI Clinical Trial and Consulting Services Enter into Co-Development Agreement with DiscGenics 13
DiscGenics Inc – Key Competitors 14
DiscGenics Inc – Key Employees 15
DiscGenics Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product News 17
02/15/2018: Cryoport to Provide DiscGenics with Cutting Edge Cold Chain Logistics Support for its Phase 1/2 Trial 17
Product Approvals 18
Oct 03, 2017: DiscGenics Receives FDA Allowance of IND to Commence Clinical Study of its Degenerative Disc Disease Therapy 18
Clinical Trials 19
Mar 22, 2018: DiscGenics Presents Promising Preclinical Study Results at ORS 2018 19
Other Significant Developments 20
Feb 15, 2018: Cryoport to Provide DiscGenics With Cutting Edge Cold Chain Logistics Support for its Phase I/II Trial 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
DiscGenics Inc, Pharmaceuticals & Healthcare, Key Facts 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DiscGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DiscGenics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
DiscGenics Inc, Medical Devices Deals, 2012 to YTD 2018 9
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DiscGenics Raises USD14 Million in Series B Financing 11
Discgenics To Raise US$3 Million In Venture Financing 12
CTI Clinical Trial and Consulting Services Enter into Co-Development Agreement with DiscGenics 13
DiscGenics Inc, Key Competitors 14
DiscGenics Inc, Key Employees 15

List of Figures
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DiscGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DiscGenics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[DiscGenics Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eurobank Ergasias SA:企業のM&A・事業提携・投資動向
    Eurobank Ergasias SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurobank Ergasias SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Kenya Electricity Generating Co Ltd:発電所・企業SWOT分析
    Kenya Electricity Generating Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Panera Bread Company:企業の戦略的SWOT分析
    Panera Bread Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Transocean Ltd.:戦略・SWOT・企業財務分析
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Traverse Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Traverse Biosciences Inc (Traverse Biosciences) is an independent bioscience company that commercializes drug candidates for the treatment of inflammatory diseases and age-related conditions affecting humans and companion animals. The company’s lead candidate TRB-N0224 is developed for canin …
  • Penta-Ocean Construction Co Ltd
    Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Penta-Ocean Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Royal KPN N.V.:企業の戦略・SWOT・財務情報
    Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report Summary Royal KPN N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PathoQuest SAS-医療機器分野:企業M&A・提携分析
    Summary PathoQuest SAS (PathoQuest) is a biotechnology company that offers game changing metagenomics approach to improve the breadth of pathogen detection. The company offers automated bioinformatics software that provide comprehensive pathogens database to produce microbiome reports. Its testing a …
  • NuScale Power LLC:企業の戦略的SWOT分析
    NuScale Power LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • AFGlobal Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary AFGlobal Corp (AFGlobal), formerly Ameriforge Group Inc is an engineering service provider that offers manufacturing, technology and precision engineering services. The company's services comprise forging, welding, machining, heat treat, fabrication and assembly, and testing and inspection. …
  • Central Electricity Generating Co:企業の戦略的SWOT分析
    Central Electricity Generating Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Visaka Industries Ltd:企業の戦略・SWOT・財務情報
    Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Visaka Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Axon Enterprise, Inc.:戦略・SWOT・企業財務分析
    Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report Summary Axon Enterprise, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Federal Agricultural Mortgage Corp (AGM):企業の財務・戦略的SWOT分析
    Summary Federal Agricultural Mortgage Corp (Farmer Mac) is a mortgage service provider that offers loan services. The organization’s services include custom solutions, credit protection, USDA guaranteed loan purchase, loan purchase, credit solutions, lending opportunities, and wholesale financing se …
  • Physiomics Plc (PYC):企業の財務・戦略的SWOT分析
    Physiomics Plc (PYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Grasim Industries Limited:企業の戦略・SWOT・財務分析
    Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Grasim Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vermont Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Vermont Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Anchor Glass Container Corp.:企業の戦略・SWOT・財務情報
    Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report Summary Anchor Glass Container Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Horama SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Horama SA (Horama) is a biotechnology company, which develops gene therapy products based on recombinant adeno-associated virus (rAAV) vectors for the treatment of rare ophthalmic diseases, including retinopathies and maculopathies. Its pipeline gene replacement products include HORA-RPE65, …
  • United Company RUSAL Plc:企業の戦略・SWOT・財務情報
    United Company RUSAL Plc - Strategy, SWOT and Corporate Finance Report Summary United Company RUSAL Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆